Cargando…
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
Glioblastoma is the most common malignant primary brain tumor. Temozolomide (TMZ) is the standard chemotherapeutic agent for this disease. However, intrinsic and acquired TMZ-resistance represents a major obstacle for this therapy. In order to identify factors involved in TMZ-resistance, we engineer...
Autores principales: | Hiddingh, Lotte, Tannous, Bakhos A., Teng, Jian, Tops, Bas, Jeuken, Judith, Hulleman, Esther, Boots-Sprenger, Sandra H., Vandertop, W. Peter, Noske, David P., Kaspers, Gertjan J.L., Wesseling, Pieter, Wurdinger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964213/ https://www.ncbi.nlm.nih.gov/pubmed/24495907 |
Ejemplares similares
-
Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis
por: Hiddingh, Lotte, et al.
Publicado: (2014) -
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer
por: Lagerweij, Tonny, et al.
Publicado: (2016) -
Functional multiplex reporter assay using tagged Gaussia luciferase
por: van Rijn, Sjoerd, et al.
Publicado: (2013) -
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
por: van Vuurden, Dannis G., et al.
Publicado: (2011) -
Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma
por: Bugiani, Marianna, et al.
Publicado: (2017)